Outcome | Trials | Participants | Effect estimate |
---|---|---|---|
Requirement for allogeneic RBC transfusion | 5 | 613 | RR 0.88 (95% CI 0.74 - 1.06, p=0.18) |
Mean number of RBC units transfused | 2 | 183 | MD -2.06 units (95% CI -8.24 - 4.12, p=0.51) |
Mean Hb (g/dL) at short-term follow-up | 3 | 242 | MD -0.25 g/dL; 95% CI -0.79 - 0.28, p=0.35 |
Mean Hb (g/dL) at mid-term follow-up | 3 | 238 | MD 0.21 g/dL; 95% CI -0.13-0.55, p=0.23 |
Mortality | 4 | 454 | RR 1.04 (95% CI 0.43 - 2.52, p=0.92) |
Infection | 2 | 347 | RR 0.89 (95% CI 0.74 - 1.08, p=0.23) |
Mean ferritin (ng/ml) at short-term follow-up | 3 | 241 | MD 193.61 ng/ml (95% CI -122.39 - 509.61, p=0.23) |
Mean ferritin (ng/ml) at mid-term follow-up | 3 | 235 | MD 358.79 ng/ml (95% CI 169.85 - 547.74, p=0.0002) |